• Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of chronic obstructive pulmonary disease (COPD). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Jan. 51 p. [97 references]

Does not apply to this measure

This measure is used to assess the percentage of patients with chronic obstructive pulmonary disease (COPD) who are asked about smoking cessation (if patient a smoker) at every visit.

The priority aim addressed by this measure is to increase the number of patients with chronic obstructive pulmonary disease (COPD) who receive information on the options for tobacco cessation and information on the risks of continued smoking.

Chronic obstructive pulmonary disease (COPD); smoking cessation

Patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who have an indication in their charts that they are users of tobacco who present for a clinic visit within the reporting month

Number of patients with documentation in the chart that the patient was asked about a change in smoking status and/or readiness to quit

• A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence

Unspecified

Current routine use

Internal quality improvement

Physician Group Practices/Clinics

Physicians

Group Clinical Practices

Unspecified

Either male or female

Unspecified

Unspecified

Historically viewed as a man's disease, more women have died of chronic obstructive pulmonary disease (COPD) than men each year since 2000.

• Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of chronic obstructive pulmonary disease (COPD). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Jan. 51 p. [97 references]

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States and is the only common chronic illness for which mortality rates continue to increase.

• Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of chronic obstructive pulmonary disease (COPD). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Jan. 51 p. [97 references]

Unspecified

Unspecified

Getting Better
Living with Illness

Effectiveness

Users of care only

Patients with chronic obstructive pulmonary disease (COPD) who have any indication on their charts that they are users of tobacco who presented to the clinic within a designated time period

Identify patients with a clinic visit in the reporting month who meet the inclusion criteria. Data may be collected by medical record review.

Randomly selected cases may be reviewed monthly.

Patients associated with provider

Inclusions
Patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who have an indication in their charts that they are users of tobacco who present for a clinic visit within the reporting month

Exclusions
Unspecified

All cases in the denominator are equally eligible to appear in the numerator

Clinical Condition
Encounter
Patient Characteristic

Time window is a single point in time

Inclusions
Number of patients with documentation in the chart that the patient was asked about a change in smoking status and/or readiness to quit

Exclusions
Unspecified

The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies.

Encounter or point in time

Medical record

Individual Case

Unspecified

Rate

Better quality is associated with a higher score

Unspecified

Internal time comparison

Unspecified

Percentage of patients with COPD who are asked about smoking cessation (if patient a smoker) at every visit.

Institute for Clinical Systems Improvement

The following Minnesota health plans provide direct financial support: Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, Metropolitan Health Plan, PreferredOne and UCare Minnesota. In-kind support is provided by the Institute for Clinical Systems Improvement's (ICSI) members.

Work Group Members: Charlene McEvoy, MD, MPH (Work Group Leader) (HealthPartners Regions Hospital); Allen Horn, MD (CentraCare Clinic) (Family Medicine); G. Paul Kerestes, MD (Allina Medical Clinic) (Family Medicine); Rhonda Schneider, RN, MSN (Marshfield Clinic) (Nursing and Health Education); Catherine Youngman, RN (HealthPartners Medical Group) (Nursing and Health Education); Anne Schullo-Feulner, PharmD (Park Nicollet Health Services) (Pharmacy); Blair Anderson, MD (HealthPartners Medical Group) (Pulmonary & Critical Care Medicine); Scott Copeman, RRT, RCP (Mayo Clinic) (Respiratory Therapy); Jeff Norton, CRT, RCP (Fairview Health Services) (Respiratory Therapy); Teresa Hunteman, RRT, CPHQ (Institute for Clinical Systems Improvement) (Facilitator); Linda Setterlund, MA, CPHQ (Institute for Clinical Systems Improvement) (Facilitator)

ICSI has adopted a policy of transparency, disclosing potential conflict and competing interests of all individuals who participate in the development, revision and approval of ICSI documents (guidelines, order sets and protocols). This applies to all work groups (guidelines, order sets and protocols) and committees (Committee on Evidence-Based Practice, Cardiovascular Steering Committee, Women's Health Steering Committee, Preventive & Health Maintenance Steering Committee and Respiratory Steering Committee).

Participants must disclose any potential conflict and competing interests they or their dependents (spouse, dependent children, or others claimed as dependents) may have with any organization with commercial, proprietary, or political interests relevant to the topics covered by ICSI documents. Such disclosures will be shared with all individuals who prepare, review and approve ICSI documents.

Charlene McEvoy, MD, has been a part of a Speaker's Bureau and participated in Research/Grant Funding for Pzifer and Spiration, Inc. All funds go to HealthPartners Research Foundation.

Barbara Yawn, MD, has received honorariums and participated in Research/Grant Funding for BJ/Pzifer, GSK and AZ. All funds paid to Olmsted Medical Center. No funds received personally.

No other work group members have potential conflicts of interest to disclose.

Measure was not adapted from another source.

2003 Dec

2009 Jan

This is the current release of the measure.

This measure updates a previous version: Institute for Clinical Systems Improvement (ICSI). Chronic obstructive pulmonary disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jan. 65 p.

• Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of chronic obstructive pulmonary disease (COPD). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Jan. 51 p. [97 references]

This NQMC summary was completed by ECRI on July 14, 2004. The summary was updated by ECRI Institute on February 25, 2005, January 25, 2006, April 4, 2007, and again on June 22, 2009.

This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.

The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties.

If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc.

All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.